Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis
批准号:
10210188
负责人:
Slobodan Beronja
金额:
$22.48万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-27 至 2022-03-31
关键词:
AdultApoptosisAutomobile DrivingBiochemistryBiological AssayCell CycleCell divisionCellsCessation of lifeDNA DamageDataDevelopmentDiseaseEngineeringEnsureEnvironmental HazardsEpidermisEpithelialEquilibriumExposure toGene TargetingGenesGenetic EpistasisGenetic ScreeningGoalsGrowthGrowth DisordersHair follicle structureHomeostasisHumanHyperplasiaImageKnowledgeLabelLifeMaintenanceMalignant NeoplasmsMediatingMethodsMitoticMolecularMusMutationOncogenesOncogenicOutcomePathologicPathway interactionsPharmacologyPhosphorylationPhysiologic pulsePhysiologicalPopulationProcessProliferatingPublishingReporterResearchSignal TransductionSkinTestingTimeTissue ExpansionTissuesWild Type Mousebasecombatdaughter cellepidermal stem cellepithelial stem cellexperimental studygenetic testingimprovedin vivointravital imagingloss of functionmanmouse modelnovelnovel therapeutic interventionprogenitorresponseself-renewalskin disorderskin organogenesisstem cell proliferationstem cellstargeted treatmenttherapy designtwo-photon
中文摘要
项目摘要
在皮肤上皮细胞中,一群能够明显地增殖、自我更新和
终末分化为有丝分裂后的后代,负责维持整个生命的组织动态平衡。
与增殖和凋亡不同,细胞命运的选择目前是通过定性或间接分析来评估的。
因此,我们缺乏对祖细胞在皮肤过程中如何平衡增殖和分化的充分了解
发育和动态平衡,或皮肤的生长障碍。
我们的长期目标是建立表皮祖细胞如何在存在的情况下平衡生长
致癌基因突变以维持组织动态平衡。为了做到这一点,我们开发了一种新的方法来直接定量
动态期和增殖期表皮祖细胞自我更新和分化的速率
成长。我们将在小鼠模型中应用我们的检测方法,以表达生理水平的
皮肤中具有结构性活性的HRAs和PIK3CA。此外,我们将使用我们最近开发的快速基因-
靶向方法,探索Ras-PI3K信号的特异性效应子和底物如何修饰表皮
体内分化。
本应用程序旨在验证以下假设:1.)分化程度增加可以平衡有丝分裂
致癌信号在维持组织动态平衡中的作用;RAS效应器PIK3CA启动一种分子
包括Akt和特定Akt底物的级联,以调节
皮肤表皮;3)表皮祖细胞对癌基因表达的反应是异质性的
受祖细胞生态位的影响。
我们的研究结果有望立即揭示细胞和分子原理
尽管有大量促进生长的突变,但仍能保持皮肤的动态平衡和功能。这些
这些发现将是开发操纵祖细胞的药理学策略的关键一步。
表皮中的潜力,用于治疗以组织生长不受限制为标志的疾病。
英文摘要
Project Summary
In skin epithelium, a population of progenitor cells distinctly capable of proliferation, self-renewal, and
terminal differentiation into post-mitotic progeny, is responsible to sustain tissue homeostasis throughout life.
Unlike proliferation and apoptosis, cell fate choices are currently assessed using qualitative or indirect assays.
As a result, we lack full understanding of how progenitors balance proliferation with differentiation during skin
development and homeostasis, or in growth disorders of the skin.
Our long-term objective is to establish how epidermal progenitor cells balance growth in the presence of
oncogenic mutations to maintain tissue homeostasis. To do so, we developed a novel assay to directly quantify
rates of progenitor cell self-renewal and differentiation in epidermis during homeostatic and hyperproliferative
growth. We will employ our assay in the mouse models engineered to express physiological levels of
constitutively active Hras and Pik3ca in the skin. In addition, we will use our recently developed rapid gene-
targeting method, to explore how specific effectors and substrates of RAS-PI3K signaling modify epidermal
differentiation in vivo.
This application aims to test the hypotheses that: 1.) Increased differentiation can balance mitogenic
effects of oncogenic signaling to maintain tissue homeostasis; 2.) Ras effector Pik3ca initiates a molecular
cascade that includes Akt and specific Akt substrates to regulate progenitor cell renewal and differentiation in
skin epidermis; and 3.) Epidermal progenitor response to oncogene expression is heterogeneous and
influenced by progenitor cell niche.
The results of our research are expected to immediately uncover cellular and molecular principles that
maintain skin homeostasis and functionality despite the abundance of growth-promoting mutations. These
findings will be a critical step in development of pharmacological strategies to manipulate progenitor cell
potential in the epidermis, to treat conditions marked by unrestrained tissue growth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fred Hutch Preclinical Ultrasound
-
批准号:10414698
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2022
-
负责人:Slobodan Beronja
-
依托单位:
Selective mRNA translation in developmental disorders
-
批准号:10413944
-
项目类别:
-
资助金额:$9.48万
-
财政年份:2020
-
负责人:Slobodan Beronja
-
依托单位:
Selective mRNA translation in developmental disorders
-
批准号:10197974
-
项目类别:
-
资助金额:$43.32万
-
财政年份:2020
-
负责人:Slobodan Beronja
-
依托单位:
Selective mRNA translation in developmental disorders
-
批准号:10700960
-
项目类别:
-
资助金额:$52.8万
-
财政年份:2020
-
负责人:Slobodan Beronja
-
依托单位:
Selective mRNA translation in developmental disorders
-
批准号:10652419
-
项目类别:
-
资助金额:$52.8万
-
财政年份:2020
-
负责人:Slobodan Beronja
-
依托单位:
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis
-
批准号:10656102
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2017
-
负责人:Slobodan Beronja
-
依托单位:
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis
-
批准号:10736269
-
项目类别:
-
资助金额:$60.09万
-
财政年份:2017
-
负责人:Slobodan Beronja
-
依托单位:
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis
-
批准号:9384220
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2017
-
负责人:Slobodan Beronja
-
依托单位:
Mechanisms of epidermal growth during development, homeostasis, and tumorigenesis
-
批准号:8726283
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2013
-
负责人:Slobodan Beronja
-
依托单位:
Mechanisms of epidermal growth during development, homeostasis, and tumorigenesis
-
批准号:8714189
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2013
-
负责人:Slobodan Beronja
-
依托单位:
Mechanisms of epidermal growth during development, homeostasis, and tumorigenesis
-
批准号:8165737
-
项目类别:
-
资助金额:$9.69万
-
财政年份:2011
-
负责人:Slobodan Beronja
-
依托单位:
Mechanisms of epidermal growth during development, homeostasis, and tumorigenesis
-
批准号:8302227
-
项目类别:
-
资助金额:$9.69万
-
财政年份:2011
-
负责人:Slobodan Beronja
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: